Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Attention Deficit Hyper Activity clinical trials
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Attention Deficit Hyper Activity: 2 US clinical trials tracked, none currently recruiting.
Attention Deficit Hyper Activity is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Kaiser Permanente, running 1 of these trials.
Enrollment posture brief
Registry condition attention-deficit-hyper-activity
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Attention Deficit Hyper Activity has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Attention Deficit Hyper Activity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Attention Deficit Hyper Activity is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests
Kaiser Permanente
NCT06388694
Process-instructed Self Neuro-Modulation (PRISM) for Attention Deficit/ Hyperactivity Disorder - Adults
NYU Langone Health
NCT04640766
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Attention Deficit Hyper Activity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Attention Deficit Hyper Activity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Attention Deficit Hyper Activity page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Attention Deficit Hyper Activity trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Kaiser Permanente sponsors the most Attention Deficit Hyper Activity trials on record, review their full trial history before evaluating a specific study. See Kaiser Permanente's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Attention Deficit Hyper Activity condition card totals 2 registered trials; most-linked intervention PRISM; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.